首页 | 本学科首页   官方微博 | 高级检索  
     

比阿培南治疗急性细菌性感染的多中心随机对照临床试验
引用本文:杜丰,苏雪松,边晓慧,李德天. 比阿培南治疗急性细菌性感染的多中心随机对照临床试验[J]. 中国临床药理学杂志, 2010, 26(2)
作者姓名:杜丰  苏雪松  边晓慧  李德天
作者单位:中国医科大学附属盛京医院,肾内科,沈阳,110004
摘    要:目的评价比阿培南(β内酰胺类抗生素)治疗急性细菌感染的有效性和安全性。方法用多中心随机开放平行对照研究方法,共入选有效病例272例,其中试验组(比阿培南)135例,给药剂量:比阿培南每次300mg,每日2次静脉滴注;对照组(亚胺培南/西司他丁钠)137例,每次亚胺培南500mg,每日3次静脉滴注。一般疗程均为7~14天,最短不少于5天。结果试验组与对照组临床痊愈率分别为62.79%和55.64%;总有效率分别为93.8%和88.72%;细菌清除率分别为90.41%和88.33%;药物不良反应发生率分别为10.37%和11.03%。结论比阿培南治疗临床常见急性细菌性感染安全、有效。

关 键 词:比阿培南  亚胺培南/西司他丁钠  细菌性感染  

Multicenter, randomized controlled clinical trial of biapenem in the treatment of acute bacterial infections
DU Feng,SU Xue-song,BIAN Xiao-hui,LI De-tian. Multicenter, randomized controlled clinical trial of biapenem in the treatment of acute bacterial infections[J]. The Chinese Journal of Clinical Pharmacology, 2010, 26(2)
Authors:DU Feng  SU Xue-song  BIAN Xiao-hui  LI De-tian
Affiliation:Department of Nephrology;Sheng Jing Hospital;China Medical University;Shenyang 110004;China
Abstract:Objective To evaluate the efficacy and safety of biapenem versus imipenem/cilastatin in the treatment of acute bacterial infections.Methods A multicenter,randomized,controlled clinical trial was carried out.In the study,135 proper patients were enrolled in biapenem(trial group),while 137 proper patients were enrolled in imipenem/cilastatin(control group).The daily dose of biapenem and imipenem/cilastatin are 600 mg and 1500 mg respectively.The treatment duration for both groups was from 7 to 14 days.Results...
Keywords:biapenem  imipenem/cilastatin  bacterial infection  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号